ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,285, issued on Oct. 14, was assigned to Cilag GmbH International (Zug, Switzerland).
"Prediction of hemostasis issues based on biomarker monitoring" was invented by Frederick E. Shelton IV (Hillsboro, Ohio), Jason L. Harris (Lebanon, Ohio) and Chad Edward Eckert (Terrace Park, Ohio).
According to the abstract* released by the U.S. Patent & Trademark Office: "A computing system may predict a complication based on measurements of related biomarker(s) obtained via one or more sensing systems, and generate an adjustment of a surgical parameter associated with a surgery. The biomarker measurements may include pre-surgical and/or in-surgical measurements. The hemostasis-related biomark...